Clinical Trial Update: Clinical Validation of the M5L Lung CAD

View source ↗

Summary

This document reports the completion of a clinical validation study for the M5L Lung CAD software in metastatic lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Candiolo Cancer Institute - IRCCS | Conditions: Lung Cancer Metastatic | Status: COMPLETED